Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference PR Newswire PALO ALTO, Calif., Sept. 8, 2023 PALO ALTO...
New one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy...
Kodiak Sciences Announces Second Quarter 2023 Financial Results and Recent Business Highlights PR Newswire PALO ALTO, Calif., Aug. 14, 2023 PALO...
Kodiak Sciences Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and...
FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads